Prevalence and Nature of Adult Hematological Malignancies Using Bone Marrow Aspiration Cytology in a Tertiary Health Facility: A Seven Year Retrospective Review
Article Sidebar
:
Main Article Content
Abstract
Bone Marrow Aspiration (BMA) is a procedure that is often used to evaluate patients with haematological disorders including haematological malignancies (HMs) which account for about 6.5% of all cancers worldwide. There is paucity of data on the prevalence and pattern of HMs from BMA cytology in Nigeria. We carried out a retrospective review to determine the prevalence and distribution of HMs among adult patients who had BMA cytology at Benue State University Teaching Hospital (BSUTH) from June 2012 to July 2019. A total of 158 BMA reports extracted from the marrow and clinic medical records were reviewed. Out of 158 adult BMA cytology reports, HMs accounted for 78(49.4%) of all haematological disorders. There was no significant gender difference. The Male 38(48.7%) to Female 40(51.3%) ratio (M:F) was 1:1.1. Their ages ranged from 16 to 85 years with the median age of 54.0 years. Out of the 78 HMs, Lymphoid neoplasms were the most prevalent 47(60.3%), the leukaemias were higher 53/78(67.9%) compared to the non-leukaemic neoplasms. Of the 53 leukaemias, those of chronic lymphoid types were more 24/53(45.3%), followed by the chronic myeloid 15/53(28.3%). Chronic lymphocytic leukaemia (CLL) was the predominant leukaemia 24/53(45.3%) as well as the most prevalent HM 24/78(30.8%), followed by chronic myeloid leukaemia (CML) 19.2%(15/78). Others were myelodysplastic syndrome (MDS) 11.5%(9/78), acute lymphoblastic leukaemia (ALL) 10.3% (8/78), multiple myeloma (MM) 10.3%(8/78), acute myeloblastic leukaemia (AML) 7.7%(6/78), non-Hodgkin's lymphoma (NHL) 6.4%(5/78), Small lymphocytic lymphoma (SLL) 2.6%(2/78) and Hodgkin's lymphoma (HL) 1.3%(1/78). In conclusion, we established high prevalence of HMs among patients who had BMA cytology evaluation at BSUTH with the preponderance of lymphoid malignancies. We advocate for inclusion of HMs in the National Health Insurance Scheme (NHIS) for full implementation and to prioritise provision of modern diagnostic equipment and treatment options for quality and optimal management of leukaemias in the center.
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Onoja AM, Nwannadi AI, Onoja AT, Aba IH, Jatau E, Osho PO, et al. Referral Pattern and Haematological Disorders in a Tertiary Hospital. J Biomed Res. Clin Pract. 2021;4(1):61–9. doi.org/10.46912/jbrcp.190
Farhana DT, Nahar Q, Choudhury S. Pattern of Haematological Disorders in a Tertiary Diabetic Hospital: A Pilot Study. J Bangladesh Coll Physicians Surg. 1970;27(3):148–54.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
Elidrissi Errahhali M, Elidrissi Errahhali M, Boulouiz R, Ouarzane M, Bellaoui M. Distribution and features of hematological malignancies in Eastern Morocco: A retrospective multicenter study over 5 years. BMC Cancer. 2016;16(1):1–10.
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. In: Histopathology. 2000.
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. THE UPDATED WHO CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES: The 2016 revision of the World Health Organization classification of lymphoid neoplasms. blood J. 2016;
Jatau ED, Joseph DE, Egesie JO, Damulak OD, Piwuna TO, Onoja AM, et al. Acute Lymphoblastic Leukaemia: A Case Report of Long-term Disease-free Survival in a Resource Limited Setting. J Biomed Res Clin Pract. 2020;3(4):457–62. doi.org/10.46912/jbrcp.182
Idris M, Shah SH, Fareed J, Gul N. An experience with sixty cases of haematological malignancies; a clinico haematological correlation., Journal of Ayub Medical College, Abbottabad : JAMC. 2004;16:51–4.
El-Jawahri A, Nelson AM, Gray TF, Lee SJ, LeBlanc TW. Palliative and end-of-life care for patients with hematologic malignancies. J Clin Oncol. 2020;38(9):944–53.
Michael K. Lymphadenopathy. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston: Butterworths; 2015. p. 711–4.
Kingsley A, Benedict N, Idongesit A, Okon Bassey B, Effiong O, Emem P, et al. Epidemiological Pattern of Adult Haematological Malignancies in a Tertiary Hospital in Cross River State. Int Res J Oncol. 2019;2(1):1–9.
Babatunde AS, Amiwero CE, Olatunji PO, Durotoye IA. Pattern of haematological malignancies in Ilorin, Nigeria: A ten year review. Internet J Hematol. 2009;5(2).
Agarwal R, Juneja S. Pitfalls in the diagnosis of haematological malignancies. New Zealand Journal of Medical Laboratory Science. 2013.
Babatunde AS, Amiwero CE, Olatunji PO, Durotoye IA. Pattern of haematological malignancies in Ilorin, Nigeria: A ten year review. Internet J Hematol. 2009;5(2):1–7.
Nwagu M, Ikusemoro A, Akinola O, Egbo O. An Eight Year Retrospective Study of the Prevalence and Socio-demographic Characteristics of Adult Blood Cancers at a Sub-Urban Teaching Hospital in Nigeria. J Res Bas Clin Sci [Internet]. 2019 Dec.5 [cited 2021Apr.3];1(3):260-5. Available from: https://jrbcs.org/index.php/jrbcs/article/view/65
Ochoga M, Tolough G, Michael A, Ikuren I, Shogo A, Abah R. Congenital Anomalies at Benue State University Teaching Hospital, Makurdi, Benue State: A Three-year Review. J Adv Med Med Res. 2018; 25(11):1-7. 10.9734/JAMMR/2018/40055
Egesie OJ, Agaba PA, Silas OA, Achenbach C, Zoakah A, Agbaji O. Presentation and survival in patients with hematologic malignancies in Jos, Nigeria: A retrospective cohort analysis. J Med Trop. 2018;20:49–56. 10.4103/jomt.jomt_8_18
Verma SK. Hematological malignancies diagnosed by bone marrow examination in a tertiary hospital at Uttarakhand, India Anuradha Kusum · Gita Negi · Dushyant Singh Gaur · Sanjeev Kishore · Harsh Meena · Anita Sharma ·. Indian J Hematol Blood Transfus. 2008;24(1):7–11.
Nwannadi A, Olusayo A, Bazuaye GN, Halim NKD, Omoti CE. The epidemiology of haematological malignancies at the university of benin teaching hospital: A ten-year retrospective study. Internet J Epidemiol. 2010;9(2).
Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy Research Network. Br J Cancer. 2011;105(11):1684–92.